Obesity and dyslipidemia in Tunisian bipolar subjects;Obésité et dyslipidémie chez des patients bipolaires Tunisiens

Annales de Biologie Clinique

Volumn 68, Issue 3, 2010, Pages 277-284

  Ezzaher, Asma ^a   Mouhamed, Dhouha Haj ^a   Mechri, Anwar ^a   Neffati, Fadoua ^a   Douki, Wahiba ^a   Gaha, Lotfi ^a   Najjar, Mohamed Fadhel ^a  

^a FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Bipolar disorder; Dyslipidemia; Obesity

Indexed keywords

LIPID;

ADULT; ARTICLE; BIPOLAR DISORDER; BLOOD; CASE CONTROL STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; MALE; MIDDLE AGED; OBESITY; TUNISIA;

ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; OBESITY; TUNISIA;

NICOTIANA TABACUM;

EID: 77952846216     PISSN: 00033898     EISSN: 19506112     Source Type: Journal    
DOI: 10.1684/abc.2010.0403     Document Type: Article

References (24)

1. Haddad FG, Brax H, Zein E, Abou el Hessen T. L'obésité et les pathologies associées dans un centre de soins au Liban. J Med Liban 2006; 54: 152-155
2. Gay C, Olie JP. Prise en charge des troubles bipolaires. Rev Prat 2005; 55: 513-520
3. McElroy SL, Kotwal R, Malhotra S, Nelson EB, Keck PE, Nemeroff CB. Are mood disorders and obesity related a review for the mental health professional. J Clin Psychiatry 2004; 65: 634-651
4. Fagiolini A, Frank E, Houck PR, Mallinger AG, Swartz HA, Buysse DJ, et al. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry 2002; 63: 528-533
5. Wyatt SB, Winters KP, Dubbert PM. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Am J Med Sci 2006; 331: 166-174
6. Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, et al. Elaboration de recommandations pour le suivi somatique des patients atteints de pathologie mentale sévère. Encéphale 2009; 35: 330-339
7. American Psychiatric Association. DSM IV, critères diagnostiques. Washington DC, 2000. Traduction française par JD Guelfi et al. Paris: Masson, 2000.
8. Elmslie JL, Silverstone JT, Mann JL, Williams SM, Romans SE. Prevalence of overweight and obesity in bipolar patients. J Clin Psychiatry 2000; 61: 179-184
9. Raji CA, Ho AJ, Parikshak NN, Becker JT, Lopez OL, Kuller LH, et al. Brain structure and obesity. Hum Brain Mapp, 2009 [Epub ahead of print].
10. McEvoy JP, Meyer JM, Goff DS, Nasrallah HA, Davis SM, Sullivan L, et al. Prevalence of the metabolic syndrome in patients with schizophrenia : baseline results from the clinical antipsychotic trials of intervention effectivenss (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Res 2005; 80: 19-32.
11. Wang PW, Sachs GS, Zarate CA, Marangell LB, Calabrese JR, Goldberg JF, et al. Overweight and obesity in bipolar disorders. J Psychiatric Res 2006; 40: 762-764
12. Chen Z, Yen ST, Eastwood BD. Does cigarette smoking have a causal effect on weight reduction ? J Family Economics Issues 2007; 28: 49-67.
13. Audiain JE, Klesges RC, Klesges LM. Relationship between obesity and the metabolic effects of smoking in women. Health psychology 1995; 14: 116-123
14. Lecerf JM. Stress and obesity. Nutr Clin Métab 2006; 20: 99-107.
15. Kahn JP. Comorbidités et troubles bipolaires. Encéphale 2006; 32: 511-514
16. Casey DE. Metabolic issues and cardiovascular disease in patients with psychiatric disorders. Am J Med 2005; 118: 15-22.
17. Lagace DC, Mcleod RS, Nachtigal MW. Valproic acid inhibits leptin secretion and reduces leptin messenger ribonucleic acid levels in adipocytes. Endocrinology 2004; 145: 5493-5503
18. Garcia-Portilla MP, Saiz PA, Bascaran MT, Martinez S, Benabarre A, Sierra P, et al. Cardiovascular risk in patients with bipolar disorder. J Affect Disord 2009; 115: 1-7.
19. Sagud M, Mihaljevic-Peles A, Pivac N, Jakovljevic M, Muck-Seler D. Platelet serotonin and serum lipids in psychotic mania. J Affect Disord 2007; 97: 247-251
20. Chung KH, Tsai SY, Lee HC. Mood symptoms and serum lipids in acute phase of bipolar disorder in Taiwan. Psychiatry Clin Neurosci 2007; 61: 428-433
21. Muldoon MF, Ryan CM, Matthews KA, Manuck SB. Serum cholesterol and intellectual performance. Psychosom Med 1997; 59: 382-387
22. Glueck CJ, Tieger M, Kunkel R, Hamer T, Tracy T, Speirs J. Hypocholesterolemia and affective disorders. Am J Med Sci 1994; 308: 218-225
23. Sagud M, Mihaljevic-Peles A, Pivac N, Jakovljevic M, Muck-Seler D. Lipid levels in female patients with affective disorders. Psychiatry Res 2009; 168: 218-221
24. Thurston JH, Hauhart RE. Amelioration of adverse effects of valproic acid on ketogenesis and liver coenzyme- A metabolism by cotreatment with panthothenate and carnitine in developing mice; possible clinical significance. Pediatr Res 1992; 31: 419-423